Folic Acid-Targeted Paclitaxel-Polymer Conjugates Exert Selective Cytotoxicity and Modulate Invasiveness of Colon Cancer Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Folic Acid-Targeted Paclitaxel-Polymer Conjugates Exert Selective Cytotoxicity and Modulate Invasiveness of Colon Cancer Cells
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 7, Pages 929
Publisher
MDPI AG
Online
2021-06-23
DOI
10.3390/pharmaceutics13070929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Cuban Propolis Component Nemorosone Inhibits Proliferation and Metastatic Properties of Human Colorectal Cancer Cells
- (2020) Yahima Frión-Herrera et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements
- (2020) Ahmed Malki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis
- (2019) Daniela Gabbia et al. Nutrients
- Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells
- (2019) Yahima Frión-Herrera et al. LIFE SCIENCES
- Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation
- (2018) Daniela Gabbia et al. PLoS One
- Antibody drug conjugates: lessons from 20 years of clinical experience
- (2016) A. W. Tolcher ANNALS OF ONCOLOGY
- p28-Mediated Activation of p53 in G 2 –M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy
- (2016) Tohru Yamada et al. CANCER RESEARCH
- Drug and protein delivery by polymer conjugation
- (2016) Antonella Grigoletto et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway
- (2016) Guohe Song et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A folate receptor-targeted lipoplex delivering interleukin-15 gene for colon cancer immunotherapy
- (2016) Xiao Liang et al. Oncotarget
- The Role of Matrix Metalloproteinases in Colorectal Cancer
- (2014) Anan Said et al. Cancers
- Poly(ethylene glycol)–paclitaxel–alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases
- (2013) Keren Miller et al. BIOMATERIALS
- Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting
- (2013) J P Tiernan et al. BRITISH JOURNAL OF CANCER
- CD133 Affects the Invasive Ability of HCT116 Cells by Regulating TIMP-2
- (2012) Min Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Matrix Metalloproteinase-2 Cleavage of the β1 Integrin Ectodomain Facilitates Colon Cancer Cell Motility
- (2012) Jakub Kryczka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance
- (2011) Michael D'Angelica et al. MODERN PATHOLOGY
- Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response
- (2011) Yu-Li Chen et al. Molecular Oncology
- Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms
- (2011) Chiara Clementi et al. MOLECULAR PHARMACEUTICS
- Relevance of folic acid/polymer ratio in targeted PEG–epirubicin conjugates
- (2010) Fabiana Canal et al. JOURNAL OF CONTROLLED RELEASE
- Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure
- (2009) Rocco Orlando et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Polymer−Drug Conjugates for Combination Anticancer Therapy: Investigating the Mechanism of Action
- (2009) Gianfranco Pasut et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antitumoral activity of PEG–gemcitabine prodrugs targeted by folic acid
- (2008) Gianfranco Pasut et al. JOURNAL OF CONTROLLED RELEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now